Yerly S - Search Results

1

The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection.

Yerly S, Junier T, Gayet-Ageron A, Amari EB, von Wyl V, Günthard HF, Hirschel B, Zdobnov E, Kaiser L; Swiss HIV Cohort Study. Yerly S, et al. AIDS. 2009 Jul 17;23(11):1415-23. doi: 10.1097/QAD.0b013e32832d40ad. AIDS. 2009. PMID: 19487906

2

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.

Yerly S, Chamot E, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1992 Aug;166(2):269-76. doi: 10.1093/infdis/166.2.269. J Infect Dis. 1992. PMID: 1353103

3

Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective study.

Yerly S, Chamot E, Déglon JJ, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1991 Nov;164(5):965-8. doi: 10.1093/infdis/164.5.965. J Infect Dis. 1991. PMID: 1940476

4

Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users.

Chamot E, Hirschel B, Wintsch J, Robert CF, Gabriel V, Déglon JJ, Yerly S, Perrin L. Chamot E, et al. Among authors: yerly s. AIDS. 1990 Dec;4(12):1275-7. doi: 10.1097/00002030-199012000-00016. AIDS. 1990. PMID: 1965126

5

Response of HIV RNA to didanosine as a predictive marker of survival.

Yerly S, Kaiser L, Mermillod B, Baumberger C, Hirschel B, Perrin L. Yerly S, et al. AIDS. 1995 Feb;9(2):159-63. AIDS. 1995. PMID: 7718186

6

Foscarnet decreases human immunodeficiency virus RNA.

Kaiser L, Perrin L, Hirschel B, Furrer H, Von Overbeck J, Olmari M, Yerly S. Kaiser L, et al. Among authors: yerly s. J Infect Dis. 1995 Jul;172(1):225-7. doi: 10.1093/infdis/172.1.225. J Infect Dis. 1995. PMID: 7797916 Clinical Trial.

7

Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load.

Yerly S, Wunderli W, Wyler CA, Kaiser L, Hirschel B, Suter S, Perrin LH, Siegrist CA. Yerly S, et al. AIDS. 1994 Oct;8(10):1503-4. doi: 10.1097/00002030-199410000-00022. AIDS. 1994. PMID: 7818826 Clinical Trial. No abstract available.

8

Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.

Yerly S, Kaiser L, Baumberger C, Hirschel B, Perrin LH. Yerly S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):358-64. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882100

9

V3 sequences in primary HIV-1 infection.

Antonioli IM, Baumberger C, Yerly S, Perrin L. Antonioli IM, et al. Among authors: yerly s. AIDS. 1995 Jan;9(1):11-7. doi: 10.1097/00002030-199501000-00002. AIDS. 1995. PMID: 7893436

10

High levels of circulating RNA in patients with symptomatic HIV-1 infection.

Baumberger C, Kinloch-de-Loës S, Yerly S, Hirschel B, Perrin L. Baumberger C, et al. Among authors: yerly s. AIDS. 1993 Nov;7 Suppl 2:S59-64. doi: 10.1097/00002030-199311002-00013. AIDS. 1993. PMID: 7909226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters